Table 1 Baseline characteristics and procedure details of the two groups.

From: Spectral shaping technology reduces the radiation dose of CT-guided lung tumor microwave ablation

Characteristics

Experimental group (n = 57)

Control group (n = 57)

p value

Sex (male/female)

27/30

24/33

 

Age, years

64.87 ± 9.79

66.11 ± 9.41

0.50

Body mass index, kg/m2

23.40 ± 2.76

23.03 ± 3.06

0.50

Lesion size, cm

1.92 ± 0.99

1.94 ± 0.90

0.90

Lesion location, n (%)

   

Upper and middle lobes

45 (78.95)

39 (68.42)

0.97

Lower lobe

12 (21.05)

18 (31.58)

Lesion density

   

Ground-glass

12 (21.05)

11 (19.30)

1.00

Mixed

9 (15.79)

9 (15.79)

Solid

36 (63.16)

37 (64.91)

Lesion pathology

   

Squamous

8 (14.04)

7 (12.28)

0.80

Adenocarcinoma

37 (64.91)

35 (61.40)

Metastatic

12 (21.05)

15 (26.32)

Patient position

   

Supine

37 (64.91)

20 (35.09)

< 0.005

Prone

11 (19.30)

16 (28.07)

Decubitus

9 (15.79)

21 (36.84)

Hand position

   

Hands up

23 (40.35)

34 (59.65)

0.10

Hands down

21 (36.84)

16 (28.07)

One hand up, one hand down

13 (22.81)

7 (12.28)

Lesion-to-pleural surface distance, cm

0.87 ± 0.98

1.05 ± 1.05

0.33

Lesion-to-vessel surface distance, cm

2.43 ± 1.83

2.45 ± 1.91

0.95

Procedure time*, min

31.96 ± 5.94

31.12 ± 6.52

0.47

Number of repeat localized scans

4.07 (2–8)

4.00 (2–7)

0.91

Technical success

100% (57/57)

100%(57/57)

1.0

Technique efficacy

100% (57/57)

98.2(56/57)

1.0